Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits

Related Experiment Video

Updated: Oct 27, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.7K

Bart Spiesschaert1,2,3,4, Katharina Angerer1,2, John Park4

  • 1Christian Doppler Laboratory for Viral Immunotherapy of Cancer, Medical University Innsbruck, 6020 Innsbruck, Austria.

Cancers
|July 24, 2021
PubMed

Insights

Small molecule compounds can enhance oncolytic virus (OV) cancer therapy by overcoming immune suppression and antiviral responses. Combining these therapies boosts antitumor effects for improved cancer treatment outcomes.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Cancer treatment increasingly focuses on stimulating antitumor immune responses using oncolytic viruses (OVs).
  • Innate antiviral responses and tumor immunosuppression can limit OV efficacy.
  • Small molecule compounds offer potential to enhance OV therapy.

Purpose of the Study:

  • To review small molecule compounds that synergize with OVs in cancer treatment.
  • To elaborate on the mechanisms of action for these compounds as monotherapies and in combination with OVs.

Main Methods:

  • Comprehensive literature review of small molecule compounds.
  • Analysis of mechanisms for antitumor effects and immune modulation.

Main Results:

  • Identified small molecules that inhibit immunosuppressive factors within the tumor microenvironment.
  • Identified small molecules that antagonize innate antiviral responses, improving OV activity.
  • These compounds demonstrate synergistic therapeutic potential with OVs.

Conclusions:

  • Small molecule compounds can significantly enhance the efficacy of oncolytic virus therapy.
  • Targeting immunosuppression and antiviral immunity with small molecules complements OV treatment strategies.
  • Combination therapies hold promise for improved cancer treatment outcomes.
Keywords:
cancer immune therapycancer therapycombination therapyimmunotherapyoncolytic virussmall molecule

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.2K
Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

12.9K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
778
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
535